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Abstract 
Background: Parkinson’s disease (PD) is well documented to be associated with elevated systemic oxidative stress 
and perceptual impairments. Furthermore, the striatum and extrastriatal cortical areas, which are involved in the coor‑
dination of perceptual functions, are impaired at an early stage of the disease. However, the possible pathophysiology 
involved in perceptual impairments remains unclear. This raises the possibility that structural abnormalities might 
mediate the relationship between oxidative stress and perceptual impairments.
Methods: We explored the differences between 27 patients with PD and 25 healthy controls in terms of serum oxi‑
dative stress, perceptual functions, and regional gray matter. A single‑level three‑variable mediation model was used 
to investigate the possible relationships between serum oxidative stress, regional gray matter volume, and different 
domains of perceptual functioning.
Results: The results demonstrate that increased serum oxidative stress (as indicated by thiobarbituric acid reactive 
substances) was associated with declined perceptual functioning in PD patients. We further explored significant gray 
matter volume reductions in the bilateral temporal gyri (middle temporal gyrus and fusiform gyrus), bilateral frontal 
gyri, limbic lobe (hippocampus and uncus), left inferior parietal lobule, right caudate nucleus, and insula in PD. Further 
mediation analysis showed that gray matter volumes in the middle temporal gyrus, inferior parietal lobule, hippocam‑
pus, and insula served as brain mediators between elevated serum oxidative stress and perceptual impairments.
Conclusions: These results suggest that higher oxidative stress levels adversely impact perceptual functions by caus‑
ing temporal and mesolimbic abnormalities.
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Background
The patterns of cognitive impairment in Parkinson’s 
disease (PD) are increasingly seen as being of clinical 
significance. In addition, specific cognitive domains may 
not only have different regional underpinnings but may 
also differ in their pathologic substrates [1, 2]. In PD, the 
presence of perceptual difficulties is common [3]. More 
specifically, these perceptual deficits may be unique 
among the cognitive impairments found in PD and are 
distinct from the effects of generalized dementia in sev-
eral regards [4, 5]. This raises the possibility that the 
pathophysiology and vulnerable regions involved in the 
perceptual impairments of patients with PD might be 
independent of the motor and cognitive statuses of such 
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underlying the deficits in perceptual functioning is essen-
tial to the development of targeted therapeutic strategies.
Studies of causative PD genes have confirmed the 
involvement of oxidative stress and apoptosis in the deg-
radation of dopaminergic neurons in PD [6]. A recent 
PET imaging study demonstrated that striatal oxida-
tive stress is enhanced in PD patients compared with 
controls and that this stress increases with the progres-
sion of disease severity, particularly in the contralateral 
striatum [7]. In addition, increased systemic oxidative 
stress has also been considered to induce ongoing CNS 
inflammation and dopaminergic neuronal death [8]. The 
production of highly toxic free radicals, which suggests 
increased oxidative stress, has been positively corre-
lated with spatial memory deficits in a rat PD model [9] 
and could be protected against through the inhibition 
of oxidative stress [10]. These findings suggest a critical 
role of increased oxidative stress on cognitive deficits 
in PD. Unfortunately, research into the potential neural 
loss mechanisms associated with the severity of cogni-
tive impairment, especially with the impaired perceptual 
functioning in PD patients, has thus far been limited [11].
Although markedly elevated neuroinflammation in 
patients with idiopathic PD has been found in the stria-
tum, as well as in extrastriatal cortices, such as the frontal 
and temporal cortical regions, compared to age-matched 
healthy controls [12–14], it is still not known whether or 
not the increased systemic oxidative stress might directly 
or indirectly affect those vulnerable regions causing per-
ceptual function impairment.  In community-dwelling 
healthy elderly subjects, elevated serum high-sensitivity 
C-reactive protein has been thought to decrease regional 
gray matter volume in the posterior and lateral aspects 
of the left temporal cortex [15]. Damage initiated either 
from the CNS or by systemic oxidative stress may be 
propagatively transferred to the temporal regions directly 
or indirectly in patients with PD [16]. Furthermore, tem-
poral regions have been reported to be the most suscep-
tible to direct pro-inflammatory cytokine injection [17]. 
It is reasonable to infer that both elevated oxidative stress 
and decreased extra-striatal gray matter volume or the 
interaction between them might affect perceptual perfor-
mance in PD, but this inference has not been tested until 
now.
The increased lipid peroxidation product, in terms 
of the level of thiobarbituric acid reactive substances 
(TBARS), along with the decreased level of endogenous 
antioxidant molecules, such as thiol in the brain, could 
contribute to dopaminergic neuronal death [18]. To 
gain a better understanding of the relationship between 
these different factors, we conducted a study examin-
ing the associations between the systemic TBARS and 
thiol levels, the structural volumetric morphology of the 
brain, and the performance intelligence quotient (IQ) 
in patients with PD and healthy control subjects. Our 
hypotheses were as follows: (1) Compared to healthy par-
ticipants, PD participants will have increased TBARS and 
reduced thiol serum levels, and also impaired perceptual 
functions; (2) The increased systemic oxidative stress will 
be related to decreased perceptual functions; (3) Regional 
gray matter volume reductions will be found in PD sub-
jects; and (4) Gray matter volume in those vulnerable 
anatomies will mediate the relationship between oxida-
tive stress level and perceptual functioning. According to 
these hypotheses, peripheral oxidative stress might serve 
as the instigator that impacts the anatomical structures of 
those most susceptible regions and thus leads, in turn, to 
a decline in perceptual functioning.
Methods
Participants
The study was approved by the Local Ethics Commit-
tee on Human Research of Kaohsiung Chang Gung 
Memorial Hospital in Taiwan. All participants or their 
guardians provided written informed consent prior 
to participation in the study. Twenty-seven right-
handed PD patients (11 men and 16 women, mean age: 
54.6 ± 9.3 years) with no previous history of neurological 
or psychiatric illnesses, psychotropic medication, or con-
traindication to magnetic resonance imaging (MRI) were 
prospectively enrolled at the Neurology Department of 
Kaohsiung Chang Gung Memorial Hospital. Patients 
were included if they had been diagnosed with idiopathic 
PD by an experienced neurologist according to the Par-
kinson’s Disease Society’s criteria for idiopathic Parkin-
son’s disease [19]. Of the 28 PD patients, ten had never 
used any anti-Parkinson’s medication, whereas the oth-
ers used dopaminergic medication (levodopa and dopa-
mine agonists). The disease severity and functional status 
of each patient were evaluated with the Unified Parkin-
son’s Disease Rating Scale (UPDRS) [20], the modified 
Hoehn and Yahr stages (HY-stage) [21], and the Schwab 
and England activities of daily living scale (SE-ADL) 
[22] in the “OFF” state, which refers to when levodopa 
appears to become less effective in eliminating motor 
symptoms and the patients are unable to function prop-
erly. The patients’ mean disease duration, defined as the 
time since the given patient subjectively noticed his or 
her first symptoms, was 4.1 ± 3.7 years. For comparison, 
25 sex- and age-matched healthy subjects (11 men and 
14 women, mean age: 50.9 ±  10.5 years) with no medi-
cal history of neurologic diseases or psychiatric illnesses, 
alcohol/substance abuse, or head injury, and with similar 
levels of education, were recruited.
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Laboratory measurements for oxidative stress factors
We evaluated the oxidative stress condition in all subjects 
by measuring the serum concentration of TBARS and 
thiol. All subjects received blood sampling on the same 
day as the MRI study and neuro-psychological testing. 
Sera were isolated from peripheral blood samples drawn 
from each subject before and after the examination.
The serum TBARS were measured based on a well-
established method for detecting lipid peroxidation 
[23]. The ability of anti-oxidative defense in response to 
increased oxidative damage was evaluated by measuring 
the serum level of total reduced thiols since serum thiols 
are physiologic free radical scavengers [24].
Neuropsychological assessment of perceptual function
A clinical psychologist performed the neuro-psycholog-
ical (NP) battery of tests from the Wechsler Adult Intel-
ligence Scale-III (WAIS-III) [25]. The WAIS-III, with 14 
subtests, allows us to summarize index scores and con-
vert to different large ability areas reliably, including three 
IQs (Verbal IQ, Performance IQ, and Full Scale IQ) and 
four Indexes (Verbal Comprehension, Working Memory, 
Perceptual Organization, and Processing Speed).
In the current study, we focused on perceptual organi-
zation and processing speed functions in PD. These bat-
teries comprise three tests for perceptual organization 
function and one test for processing speed function. The 
tests for perception organization function include picture 
completion, block design, and matrix reasoning tests. We 
sum the results from these tests to come up with an index 
score which represents the aggregate abilities of percep-
tual organization function.
The test for processing speed was a digit symbol-cod-
ing test which examines several cognitive processes of 
participants, such as detecting a test digit, searching for 
the corresponding symbol, and maintaining the symbol 
representation. We then further added scaled scores of 
perceptual organization and processing speed functions 
and converted them into the performance IQ.
MR image acquisition
Volumetric structural MRI scans were acquired on a 
GE Signa 3T whole-body MRI scanner (General Elec-
tric Healthcare, Milwaukee, WI, USA) using an eight-
channel phase array head coil at the Kaohsiung Chang 
Gung Memorial Hospital in Taiwan. Whole brain three-
dimensional T1 weighted images were collected for each 
participant using an inversion-recovery fluid-attenuated 
fast spoiled gradient-recalled echo pulse sequence with 
the following imaging parameters: repetition time (TR)/
echo time (TE)/inversion time (TI)  =  9.5/3.9/450  ms; 
flip angle  =  15 degrees; number of excitations 
(NEX) = 1; field of view (FOV) = 240 × 240 mm2; matrix 
size = 512 × 512; voxel size = 0.47 × 0.47 × 1.3 mm3; 
and slice number  =  110 axial slices (without inter-
slice gaps). In order to identify any brain abnormali-
ties, an additional volumetric axial T2-weighted fast 
spin-echo sequence (TR/TE =  4200/102  ms; echo train 
length  =  18; NEX  =  2; FOV  =  240  mm2; slice thick-
ness = 5 mm; matrix size = 320 × 256 and 18 slices) and 
axial T2-weighted inversion-recovery fluid-attenuated 
sequence (TR/TE/TI  =  8000/100/2000  ms; NEX  =  1; 
FOV  =  240  mm2; slice thickness  =  5  mm; matrix 
size  =  320*256 and 18 slices) were used in the same 
imaging session.
T1-weighted structural MRI scans were analyzed with 
voxel-based morphometry (VBM) [26] using the VBM8 
toolbox (http://dbm.neuro.uni-jena.de), which was 
implemented using the Statistical Parametric Mapping 
software program (SPM8, Wellcome Institute of Neurol-
ogy, University College London, UK, http://www.fil.ion.
ucl.ac.uk/spm/) with default settings. All the image pro-
cessing procedures, including tissue segmentation, study-
specific template construction, and spatial normalization, 
were conducted according to a previous study [27] and 
are summarized in the Additional file  1 for the present 
study.
Statistical analysis
Analysis of demographic data, neuropsychological 
assessments, and global tissue volumes
The demographic data, including age, sex, and educa-
tion, were compared among the study groups by the 
2-sample Student’s t test and Pearson’s Chi square test, 
where appropriate. Differences in the serum concentra-
tions of TBARS and thiol, and in neuropsychological 
assessment scores and global tissue volumes, including 
the GM, WM, CSF volumes, and TIV, were analyzed 
using an analysis of covariance (ANCOVA) model with 
the participant’s age, sex, and education values as covari-
ates. The threshold for all statistical significance was set 
at P  < 0.05 (SPSS software, version 17, for Windows, 
Chicago, IL, USA).
Voxel‑wised gray matter volume comparisons 
between healthy controls and patients with PD
To examine between-group differences in gray mat-
ter volume, we used a general linear model which was 
implemented in SPM8 to compare modulated gray mat-
ter segments between healthy controls and patients with 
PD at the level of the whole brain. All of the processes 
were conducted according to a previous study [27] and 
are summarized in the Additional file  1 for the present 
study. The resultant statistical inferences were considered 
significant under the criteria of cluster level family-wise 
error (FWE) corrected P value <0.05, with a cluster size 
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of at least 184 voxels, based on the results of the Monte 
Carlo simulation (3dClusterSim with the following 
parameters: single voxel P value <0.005, FWHM = 7 mm 
with GM mask and 10,000 simulations).
Mediation analysis
A single-level three-variable mediation model [28], 
illustrated in Fig.  1, was used to investigate the causal 
relationships between oxidative stress, regional GM vol-
ume, and perceptual function. Mediation analysis tests 
whether the direct effect of an independent variable on 
a dependent variable can be explained by the indirect 
influence of the mediating variable. The primary hypoth-
esis of this analysis asks whether the effect of the oxida-
tive stress level (independent variable) on the perceptual 
function (dependent variable) was explained indirectly by 
the regional gray matter volume changes (mediator) with 
significant group main effect. In order to examine this 
indirect effect, the Mediation toolbox (http://wagerlab.
colorado.edu/tools) with an accelerated bias-corrected 
bootstrap test of statistical significance was used (10,000 
bootstrap samples). The path model jointly tested three 
effects of interest that are required if a regional GM vol-
ume links oxidative stress with the perceptual function: 
(a) the effect of the independent variable (TBARS level) 
on the mediator (regional gray matter volume) (indi-
rect effect, path a); (b) the effect of the mediator on the 
dependent variable (perceptual performances) by con-
trolling the effect for the TBARS (indirect effect, path 
b); and (c) the mediation effect a × b which is defined as 
the reduction of the relationship between the independ-
ent and dependent variables (TBARS—perceptual per-
formance) (total relationship, path c) by including the 
mediator into the model (direct path, path c′). We set 
the statistical significance threshold at 0.05 for all the rel-
evant paths [29].
Fig. 1 The diagram of the mediation hypothesis framework. In this mediation hypothesis framework, we want to identify the potential anatomical 
region which exhibited the mediation effect between oxidative stress level and perceptual function. We selected the oxidative stress as a predictor 
(X), perceptual functions as an outcome variable (Y), and regional gray matter with significant main disease effect (investigated from VBM analysis) 
as potential mediators (M). The three components of single level mediation analysis address the relationship between these variables. Indirect “path 
a” investigates the relationship between oxidative stress level and regional gray matter volume. Indirect “path b” investigates whether the regional 
gray matter volume predicts the perceptual functions after adjusting the oxidative stress level. Mediation a*b effect investigates whether regional 
gray matter volume plays the role of mediator between the oxidative stress level and perceptual functions. In addition, path c’ and c represent the 
total relationship between oxidative stress and perceptual functions with/without adjustments to regional gray matter volume, respectively. PIQ 
performance intelligence quotient, TBARS thiobarbituric acid reactive substances, VBM voxel‑based morphometry
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Results
Demographic data, perceptual scores, and serum 
concentrations of TBARS and thiol of PD patients 
and healthy controls
The demographic and clinical data of the participants are 
shown in Table 1. In the ANCOVA analyses, the patients 
with PD had worse performance on the perceptual func-
tion tests, including the picture completion (P = 0.007), 
block design (P = 0.002), matrix reasoning (P = 0.020), 
and digit symbol-coding tests (P < 0.001). Further analy-
sis showed that the patients with PD had a worse mean 
score in terms of the perceptual organization index 
(P  =  0.004). Moreover, when that mean was combined 
with the mean score for digital symbol-coding, the mean 
performance IQ in patients with PD was also found to be 
worse than the mean for the healthy controls (P = 0.002).
The mean serum concentration of TBARS was sig-
nificantly higher in the PD patients than in the con-
trols (P < 0.001). The mean serum concentration of free 
thiol was lower in PD patients than in the controls, but 
the difference failed to achieve statistical significance 
(P = 0.191). Since only the serum TBARS level revealed a 
significant group difference, the following correlation and 
mediation analyses were primarily focused on and car-
ried out with regard to the TBARS levels.
Gray matter volume reduction in patients with Parkinson’s 
disease
Compared to healthy controls, PD patients showed a 
significant GM volume reduction in the following brain 
regions: (1) bilateral temporal gyri (middle temporal 
gyrus and fusiform gyrus), (2) bilateral frontal gyri, (3) 
limbic lobe (hippocampus and uncus), (4) left inferior 
parietal lobule, (5) right caudate nucleus, and (6) insula. 
We did not find increased GM volume in PD patients 
compared with the healthy controls (Additional file  2: 
Table S2; Fig. 2).
Correlations between serum TBARS and perceptual 
functions
Consistent with our hypotheses, elevated serum oxida-
tive stress levels were associated with poorer perfor-
mances on several perceptual subtests, which suggested 
that systemic inflammation might degrade general per-
ceptual functions directly or indirectly in PD (Table  2). 
We found that higher TBARS levels were associated with 
worse matrix reasoning (p  =  0.017, r  =  −0.337), digit 
symbol (p = 0.044, r = −0.286), and perceptual organiza-
tion index (p = 0.035, r = −0.299) scores. We also found 
that high TBARS levels were borderline significantly cor-
related with worse block design (p = 0.066, r = −0.262), 
picture completion (p = 0.058, r = −0.270), and perfor-
mance IQ (p = 0.062, r = −0.266) scores.
Brain mediators of oxidative stress on perceptual functions
TBARS‑digit symbol relationship mediator
Single-level three-variable mediation analysis revealed 
atrophy of middle temporal gyrus that negatively 
Table 1 Analysis of  demographic variables, clinical vari-
ables, global anatomical measurements, and  cognitive 
assessments between  the healthy controls and  patients 
with Parkinson’s disease
Means and standard deviations of raw scores for the healthy control group and 
the patients with Parkinson’s disease. For each variable, the p value indicates the 
significance level of the appropriate statistical test comparing the raw scores of 
the control group and the patients with Parkinson’s disease
CSFV cerebrospinal fluid volume, GMV gray matter volume, MMSE mini–mental 
state examination, Modified H&Y stage modified Hoehn and Yahr stages, PD 
Parkinson’s disease, PIQ performance intelligence quotient, SE-ADL Schwab 
and England activities of daily living scale, TBARS thiobarbituric acid reactive 
substances, TIV total intracranial volume, UPDRS Unified Parkinson’s Disease 
Rating Scale, WMV white matter volume
a Two sample unpaired t test
b Chi square test
c Analysis of covariance test which adjusted for age, sex, education, and TIV
d Analysis of covariance test which adjusted for age, sex, and education
e For Modified HY-stage, the maximum stage is 5
f For the SE-ADL, the minimum score is 0, suggesting vegetative functions; the 
maximum score is 100, suggesting completely independent
* P value < 0.05





Age (years) 54.59 ± 9.32 50.88 ± 10.51 0.183a
Sex (male/female) 11/16 11/14 1.000b
Education (years) 9.22 ± 4.91 11.76 ± 4.27 0.053a
GMV (l) 0.54 ± 0.06 0.57 ± 0.05 0.58c
WMV (l) 0.54 ± 0.05 0.57 ± 0.05 0.108c
CSFV (l) 0.22 ± 0.03 0.21 ± 0.03 0.412c
TIV (l) 1.29 ± 0.11 1.35 ± 0.11 0.032d*
UPDRS I 3.37 ± 2.53 – –
UPDRS II 10.44 ± 8.06 – –
UPDRS III 23.48 ± 12.64 – –
UPDRS total score 37.15 ± 21.69 – –
Modified HY‑stagee 1.98 ± 1.05 – –
SE‑ADLf 85.19 ± 17.18 – –
MMSE 25.04 ± 4.28
PIQ 85.78 ± 16.93 104.52 ± 20.16 0.002d*
 Perceptual organi‑
zation index
85.74 ± 17.75 101.52 ± 17.38 0.004d*
  Picture comple‑
tion
7.33 ± 3.14 10.52 ± 4.44 0.007d*
  Block design 7.07 ± 3.23 9.96 ± 2.88 0.002d*
  Matrix reason‑
ing
8.07 ± 3.82 10.60 ± 3.19 0.020d*
 Processing speed index
  Digit symbol 6.81 ± 3.08 10.24 ± 2.30 <0.001d*
TBARS (μM) 14.5 ± 3.95 9.10 ± 2.50 <0.001*
Thiol (μM) 1.40 ± 0.50 1.50 ± 0.30 0.191
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mediated the TBARS-digit symbol relationship. The mid-
dle temporal gyrus volume reduction was negatively asso-
ciated with TBARS levels, but predicted impaired digit 
symbol test performance (Coefa  =  −0.007, Pa  <  0.001; 
Coefb = 15.55, Pb = 0.003; Coefab = −0.10, Pab = 0.005). 
This finding suggests that the serum level of TBARS plays 
a role in contributing negative impact on digit symbol 
test scores through the middle temporal gyrus. Figure 3A 
shows path diagrams and scatterplots for path analyses 
in middle temporal gyrus. We also found that volume 
reductions in the inferior parietal lobule (Coefab = −0.10, 
Pab = 0.042), hippocampus (Coefab = −0.06, Pab = 0.042), 
and insula (Coefab = −0.12, Pab = 0.025) can negatively 
mediate the TBARS-digit symbol relationship (Table 3).
TBARS‑block design relationship mediator
The middle temporal gyrus volume reduction was neg-
atively associated with TBARS level, and predicted 
impaired block design test scores (Coefa  =  −0.007, 
Pa  <  0.001; Coefb  =  19.21, Pb  <  0.001; Coefab  =  −0.13, 
Pab = 0.004). This finding suggests that the serum level of 
TBARS also plays a role in contributing negative impact 
on block design test through the middle temporal gyrus 
(Fig.  3B). We also found that volume reductions in the 
hippocampus (Coefab = −0.06, Pab =  0.042), and insula 
(Coefab = −0.14, Pab = 0.014) can negatively mediate the 
TBARS-block design relationship (Table 3).
TBARS‑perceptual organization index relationship mediator
Since the perceptual organization index is the sum of 
the picture completion, block design, and matrix rea-
soning scores, we also found that volume reductions in 
the middle temporal gyrus (Coefab = −0.63, Pab = 0.006) 
Fig. 2 Reduced gray matter volume in PD using a whole brain voxel‑wised exploratory analysis. Significant (cluster level statistics, p value <0.05, 
family‑wise error corrected) regional gray matter volume reduction in a patient with Parkinson’s disease revealed by whole brain VBM analysis. a The 
spatial distribution of regional gray matter volume reduction. b VBM results are overlaid onto the mean group DARTEL‑T1 template. The patient with 
Parkinson’s disease showed lower regional gray matter volumes in the left middle temporal gyrus, left fusiform gyrus, left insula, left inferior parietal 
lobule, right caudate, right hippocampus, right superior frontal gyrus, and bilateral medial frontal gyrus. The hot color bar indicates the T scores scale. 
DARTEL diffeomorphic anatomical registration through exponentiated lie algebra, L left, R right, VBM voxel‑based morphometry
Table 2 Associations between  oxidative stress level 
(TBARS) and  perceptual functions after  adjustments 
for age and sex
The results of partial correlation analysis between oxidative stress level and 
perceptual functions (adjusted for age, sex and education) were illustrated as 
correlation coefficients and corresponding p values
TBARS thiobarbituric acid reactive substances
* Indicates a P value of less than 0.05
Clinical variable Correlation coefficient p value
Performance IQ −0.266 0.062
Perceptual organization index −0.299 0.035*
Picture completion −0.270 0.058
Block design −0.262 0.066
Matrix reasoning −0.337 0.017*
Digit symbol −0.286 0.044*
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(Fig.  3C), hippocampus (Coefab  =  −0.34, Pab  =  0.031), 
and insula (Coefab = −0.70, Pab = 0.017) can negatively 
mediate the TBARS-perceptual organization index rela-
tionship (Table 3).
TBARS‑performance intelligence quotient relationship 
mediator
Lastly, performance IQ is the sum of the picture com-
pletion, block design, matrix reasoning, and digit 
symbol-coding scores, and we also found that volume 
reductions in the middle temporal gyrus (Coefab = −0.56, 
Pab  =  0.024) (Fig.  3D) and insula (Coefab  =  −0.68, 
Pab =  0.015) can negatively mediate the TBARS-perfor-
mance IQ relationship (Table 3).
Discussion
Summary
Consistent with our hypothesis and in line with the 
extant literature, patients with PD experienced higher 
serum oxidative stress and worse perceptual functions. 
Furthermore, we identified gray matter atrophy through-
out much of the cortex, including anatomical loca-
tions that typically appear to be particularly sensitive to 
the effects of inflammation, such as the temporal lobe, 
Fig. 3 Middle temporal gyrus as potential brain mediator between oxidative stress level and different perceptual functions. Mediation path dia‑
gram showing the relationship between oxidative stress level (predictor, TBARS), regional gray matter volume (mediator, using MTG for visualization 
purpose, the other potential brain mediators and full statistics are presented in Table 3), and different perceptual functions (dependent variable, 
A DS; B BD; C POI; and D PIQ). The dark solid and light dashed lines indicate the significant/non‑significant relationship between each variable, 
respectively. The hypothesized causalities are presented as one-directional arrows. The corresponding mean path coefficients with standard errors of 
the path a, path b, path c’, and mediation a*b effects for each mediation model are also labeled. The correlation scatterplots indicate the relation‑
ship between oxidative stress level, MTG gray matter volume, and different perceptual functions across whole study groups (“path a” and “path b” 
effects, respectively). The histogram shows the bootstrap estimates of mediation a*b effect distribution of MTG for each mediation model. The light 
gray shading shows the 95 % confidence intervals of bootstrap estimates and the vertical line indicates the null hypothesis value of zero. *p < 0.05, 
**p < 0.01, ***p < 0.001. BD block design, DS digit symbol, MTG middle temporal gyrus, PIQ performance intelligence quotient, POI perceptual 
organization index, TBARS thiobarbituric acid reactive substances
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hippocampus, and insula [30]. We further demonstrated, 
for the first time, that gray matter volume atrophy in the 
temporal lobe, hippocampus, insula, and parietal lobe 
mediate the relationships between TBARS levels and 
general perceptual function scores. This suggests that 
higher oxidative stress levels are associated with poor 
perceptual functions by means of smaller temporal and 
mesolimbic volumes and that those regions support the 
retention of  visual memories, the processing of sensory 
inputs,  the comprehension of language, the storing of 
new memories and emotions in a manner that may dif-
fer from the way in which the prefrontal cortex supports 
executive functioning in PD.
Pathophysiology of elevated oxidative stress in PD
Studies have demonstrated that an imbalance in pro-
oxidant/antioxidant homeostasis can enhance the gen-
eration of toxic reactive oxygen species [31] and may be 
related to disease severity in PD [32]. The TBARS level 
is one of the markers of oxidative stress, and has been 
found to be elevated not only in the substantia nigra but 
also in the CSF and plasma in PD [33–35]. In addition, 
many cytokines, as well as TBARS, are also markers of 
reactive oxygen species (ROS) activity, which can worsen 
central neuron cell injury through the elevation of reac-
tivated microglia in the substantia nigra [36]. Cytokines 
produced in the brain can freely diffuse past the blood–
brain barrier  (BBB), a phenomenon which has been 
demonstrated to induce memory impairments [37]. Our 
study supports the previous hypothesis that oxidative 
stress is implicated in the pathogenesis of PD.
In addition to the  nigrostriatal  region, inflammation 
activated microglial cells in PD were also observed in 
various brain regions, such as the  hippocampus, tem-
poral lobe, and other regions of the cerebral cortex [30]. 
Actually, increased oxidative stress/inflammation has 
also been found to be associated with temporal lobe 
damage in aging [38] due to atherosclerosis and Alzhei-
mer’s disease [39], with the pathological accumulation 
of amyloid and neurofibrillary tangles. Two leading fac-
tors might contribute this temporal lobe vulnerability: 
relatively high receptor and messenger RNA expression 
for proinflammatory cytokines [40] in those regions and 
higher links to portions of the salience network, such as 
the insula, which has a role in regulating the immune 
system and can enhance the peripheral inflammatory 
conditions [41] and subsequently affect the neural organ-
ization of semantic memory [42]. From animal studies, it 
has been demonstrated that injections of inflammatory 
cytokines into the hippocampus and the overexpression 
of IL-1 messenger RNA in the hippocampus selectively 
deteriorate spatial and contextual memory processes 
[43]. In addition, elevated peripheral inflammation can 
stimulate IL-1 expression within the central nervous sys-
tem, including the medial temporal lobe, and generates 
increased cytokine expression with subsequent impacts 
Table 3 The potential brain mediators of  the relationships between  oxidative stress and  the different perceptual func-
tions
The corresponding statistical results of each path and mediation effect between the oxidative stress (independent variable), perceptual functions (dependent 
variable), and anatomical regions with significant disease effect (mediators) are described in terms of corresponding path coefficient, z value, and p value. The 
anatomical regions were considered as potential brain mediators between oxidative stress level and perceptual functions if statistical significance, as indicated by a 
p of less than 0.05, was found in each of the following three effects in corresponding mediation analysis. (1) Indirect Path a: the relationship between oxidative stress 
level and the regional gray matter volume; (2) indirect Path b: the relationship between the regional gray matter volume and perceptual functions as determined by 
controlling the oxidative stress level and (3) Mediation a × b effect. All mediation analyses were conducted using the Mediation toolbox
Pcoef path coefficient, HIPP hippocampus, INS insula, IPL inferior parietal lobule, MTG middle temporal gyrus, PIQ performance intelligence quotient; POI, perceptual 
organization index
Clinical variable Anatomy name Path a Path b a × b Path c’
pcoef z p pcoef z p pcoef z p pcoef z p
Digit symbol MTG −0.007 −3.97 <0.001 15.55 2.94 0.003 −0.10 −2.82 0.005 −0.11 −2.12 0.034
IPL −0.009 −3.30 <0.001 11.29 2.28 0.023 −0.10 −2.04 0.042 −0.11 −2.20 0.028
HIPP −0.004 −2.49 0.013 18.25 −1.58 0.030 −0.06 −2.03 0.042 −0.15 −2.25 0.025
INS −0.005 −2.84 0.005 24.73 2.38 0.017 −0.12 −2.24 0.025 −0.09 −2.17 0.030
Block design MTG −0.007 −3.40 <0.001 19.21 4.02 <0.001 −0.13 −2.91 0.004 −0.09 −2.67 0.008
HIPP −0.004 −2.46 0.014 16.85 2.53 0.011 −0.06 −2.03 0.042 −0.15 −2.55 0.011
INS −0.005 2.86 0.004 29.32 3.03 0.002 −0.14 −2.47 0.014 −0.07 −2.56 0.011
POI MTG −0.007 −3.64 <0.001 92.59 2.84 0.005 −0.63 −2.74 0.006 −0.71 −2.72 0.007
HIPP −0.004 −2.44 0.015 99.80 2.42 0.015 −0.34 −2.15 0.031 −1.01 −2.71 0.007
INS −0.005 −2.99 0.003 142.70 2.88 0.004 −0.70 −2.39 0.017 −0.65 −2.75 0.006
PIQ MTG −0.007 −3.59 <0.001 82.38 2.60 0.009 −0.56 −2.26 0.024 −0.68 −2.62 −0.009
INS −0.005 −2.96 0.003 139.79 2.83 0.005 −0.68 −2.43 0.015 −0.57 −2.56 0.010
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on temporal lobe-dependent memory [44]. The vagus 
nerve, which serves as a neurally mediated immune-
brain pathway, can also enhance hippocampal activity by 
peripheral inflammatory challenge and electrical stimu-
lation [45, 46]. Taken together, these data demonstrate 
the sensitivity of human medial temporal lobe structures 
to systemic oxidative stress/inflammation and provide 
mechanistic insights relevant to the broader literature 
linking severe or chronic inflammation to the attrition of 
human memory.
Gray matter atrophy serves as a mediator of oxidative 
stress on perceptual functions
In a previous cortical thickness analysis of PD with mild 
cognitive impairment, patient groups revealed wide-
spread cortical thinning compared with controls, includ-
ing thinning of the right inferior temporal gyrus, left 
superior parietal cortex, precuneus, lateral occipital, tem-
poral gyri anterior cingulate, and superior frontal gyri [1]. 
The same study also found that memory and visuospatial 
performance, the core feature of perceptual function, 
were associated with temporoparietal and superior fron-
tal gyri thinning. Our results replicated these previous 
findings and also consistently demonstrated the inter-
action between perceptual functional impairment and 
volume atrophy in the middle temporal gyrus, inferior 
parietal lobe, hippocampus, and insula. Although fewer 
cortical regions were found to be involved in this study, 
the relatively small sample size and younger patient group 
might have led to these slightly different results. Further-
more, different gray matter quantitative morphometrical 
evaluation methods which are sensitive to different prop-
erties of gray matter tissue (i.e., volume vs. cortical thick-
ness) might also have led to the different outcomes. We 
do believe, however, that the results of the current study, 
together with those of the previous investigation, indicate 
that particular cortical atrophy can serve as a marker for 
perceptual function decline in early PD.
The test of mediation amounts to a test of whether 
controlling for each brain mediator explains a signifi-
cant amount of the covariance between the independ-
ent variable and the dependent variable. In the initial 
analyses, we found that higher serum TBARS levels were 
associated with worse perceptual functions. We fur-
ther examined whether the relationship between serum 
TBARS levels and perceptual functions was explained 
indirectly by greater damage to perceptual functional 
specific anatomies in patients with PD using media-
tion analyses. We found that the middle temporal lobe 
and insula, as well as the hippocampus, play the central 
roles in mediating most of the TBARS-perceptual func-
tion relationships. Interestingly, the caudate nucleus 
and frontal lobe volume reduction, which is a hallmark 
of PD, failed to mediate the association between oxida-
tive stress and perceptual function. Actually, perceptual 
impairment in PD occurs not only on visuomotor tasks 
requiring a complex motor response such as drawing 
but also on visuoperceptual tasks that require a limited 
motor response. Furthermore, this perceptual impair-
ment is not related to a decrement in intellectual abili-
ties and can be clearly distinguished from dementia [4]. 
In the present study, though the results could not exclude 
the influence of TBARS on other aspects of systemic sta-
tus, they suggest that TBARS may play a particular role 
in the perceptual deficits observed in PD. Another expla-
nation might be the ceiling effect, which suggests that 
inflammation occurs earlier in the striatum and then is 
followed by inflammation in the temporal lobe and hip-
pocampus, resulting in the sequential clinical presenta-
tions progressing from movement disorders to cognitive 
impairments. These results, however, should be inter-
preted with caution.
The interpretation of the findings here must be tem-
pered by some of the limitations of the present study. We 
do not know the temporal relationships between periph-
eral inflammation, symptomatology, and anatomical 
integrity. Further task design or longitudinal evaluation 
with manually controlled systemic oxidative stress levels 
in animal models should be carried out in the future. In 
addition, the measurement of only a few biomarkers of 
oxidative damage cannot be considered a valid tool for 
exploring the multifaceted, complex oxidant/antioxidant 
imbalance in PD. Furthermore, the oxidant/antioxidant 
balance of PD patients may be influenced by a multi-
tude of parameters. The interactions between the CNS 
and systemic oxidative stress and the effect of individual 
genetic variations and physical exercise could also affect 
either the systemic oxidative stress or the brain volume, 
and these interactions were not well evaluated in the pre-
sent study. While systemic oxidative stress is also likely 
to have widespread effects on the brain tissue, the spe-
cific anatomical volumes that mediate a given cognitive 
function are likely to differ depending on the examina-
tions being assessed [47]. In addition, recent research 
suggests that network-based rather than regional ana-
tomic involvements contribute to the neurodegeneration 
and behavioral differences seen in PD, such that assess-
ing structural or functional connectivity between brain 
regions associated with these phenotypes would clarify 
the complex neural network involved in oxidative stress–
cognition relationships.
Conclusions
Although extensive structural alterations might occur in 
PD, our results highlight the possibility that only some 
vulnerable anatomies, such as the temporal lobe and 
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hippocampus, might mediate the systemic oxidative 
stress seen in certain phenotypes of PD. This model has 
important implications for understanding how systemic 
oxidative stress may result in the development of cogni-
tive malfunctions in PD and might provide novel targets 
for candidate neuroprotective therapies.
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